Alexion Pharmaceuticals, Inc.

MACKENZIE FINANCIAL CORP ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/11/2021

Shares

12,876

Value ($000)

2,365

Weight

0.0%

2013 Q4 - 2021 Q2 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/11/2021	2,365	0.0%	12,876	6/30/2021
2021 Q1	5/14/2021	2,536	0.0%	16,585	3/31/2021
2020 Q4	2/10/2021	1,971	0.0%	12,614	12/31/2020
2020 Q3	11/13/2020	2,208	0.0%	19,294	9/30/2020
2020 Q2	8/13/2020	2,317	0.0%	20,647	6/30/2020
2020 Q1	5/14/2020	479	0.0%	5,340	3/31/2020
2019 Q4	2/13/2020	418	0.0%	3,865	12/31/2019
2014 Q2	8/11/2014	20,925	0.1%	133,920	6/30/2014
2014 Q1	5/14/2014	20,650	0.1%	135,740	3/31/2014
2013 Q4	2/11/2014	19,277	0.1%	145,070	12/31/2013